Hugely promising cancer drug dostarlimab is one step closer to being widely available, after the Food and Drug Administration ...
The U.S. Food and Drug Administration has approved Novo Nordisk's drug for the prevention or reduction of bleeding episodes ...
On December 5, 2024, just in time for the holidays, the U.S. Food and Drug Administration (“FDA” or the “Agency”) released a draft guidance ...
A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...
Earlier this month, the US Food and Drug Administration (FDA) issued new draft guidance regarding their accelerated approval pathway for new drugs ...
Alembic Pharmaceuticals Limited on Friday announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Divalproex ...
The U.S. Food and Drug Administration has approved Ionis Pharmaceuticals' drug to treat a rare genetic disorder, making it ...
A new review published in Blood Cancer Discovery outlines a major multiple myeloma research project that supported a key ...
Executives at a local company believe they have a quicker and less expensive path to get their new drug approved.
Although patients with cancer value speedy access to new drugs, they are often willing to wait for strong evidence ...
Granules Pharmaceuticals, Inc (GPI) has received approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Lisdexamfetamine Dimesylate chewable ...
A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions.